The Ohio State University Investigational Drug Services is a clinical research site located in Columbus, Ohio, United States 43210.
Crixeo Clinical Trials Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.
The Ohio State University Investigational Drug Services has participated in 6 clinical trials.
Therapeutic areas: Non Small Cell Lung Cancer ALK Positive or ROS1 Positive, Uveitic Macular Edema, Sickle Cell Anemia.
Sponsors: Pfizer, Hoffmann-La Roche, GlycoMimetics Incorporated.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Ohio · View every site in Columbus
Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Ohio State University Investigational Drug Services has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Ohio State University Investigational Drug Services has 6 clinical trials on record. Their work covers Non Small Cell Lung Cancer ALK Positive or ROS1 Positive, Uveitic Macular Edema, Sickle Cell Anemia.
The Ohio State University Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.